MX2023000423A - Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades. - Google Patents
Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades.Info
- Publication number
- MX2023000423A MX2023000423A MX2023000423A MX2023000423A MX2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A
- Authority
- MX
- Mexico
- Prior art keywords
- trehalose
- ailment
- prebiotic
- inhibiting
- inducing microorganisms
- Prior art date
Links
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 title abstract 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 title abstract 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 title abstract 4
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- 235000013406 prebiotics Nutrition 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000004761 scalp Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con un uso novedoso de trehalosa. Más particularmente, la presente invención se relaciona con un uso novedoso de trehalosa para promover la salud del cuero cabelludo. Por lo tanto, la presente invención proporciona la utilización de trehalosa como prebiótico para inhibir los microorganismos inductores de afecciones cuando se aplica sobre una superficie externa del cuerpo humano.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020101302 | 2020-07-10 | ||
EP20192342 | 2020-08-24 | ||
PCT/EP2021/065735 WO2022008163A1 (en) | 2020-07-10 | 2021-06-11 | Use of trehalose as prebiotic for inhibiting ailment inducing microorganisms |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023000423A true MX2023000423A (es) | 2023-02-09 |
Family
ID=76305940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023000423A MX2023000423A (es) | 2020-07-10 | 2021-06-11 | Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades. |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230270653A1 (es) |
EP (1) | EP4178528A1 (es) |
CN (1) | CN115867347A (es) |
MX (1) | MX2023000423A (es) |
WO (1) | WO2022008163A1 (es) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3202135B2 (ja) * | 1994-08-10 | 2001-08-27 | カネボウ株式会社 | 頭髪化粧料 |
US20020165168A1 (en) * | 1995-12-16 | 2002-11-07 | Joachim Bunger | Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
EP1340486A1 (de) * | 2002-03-01 | 2003-09-03 | Cognis France S.A. | Verwendung von Zuckerestern |
EP3143983A1 (en) * | 2003-02-13 | 2017-03-22 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | External dermatological formulation comprising saccharide derivative of alpha, alpha-trehalose |
DE102004032734A1 (de) | 2004-03-18 | 2005-10-06 | Henkel Kgaa | Präbiotisch wirksame Substanzen für Deodorantien |
WO2013070893A1 (en) | 2011-11-08 | 2013-05-16 | The Procter & Gamble Company | Method of making cosmetic compositions containing a prebiotic |
CN103250880B (zh) * | 2013-06-03 | 2015-03-04 | 史莹华 | 一种海藻糖—蒙脱石纳米复合物作为饲料添加剂的新应用 |
FR3064473B1 (fr) * | 2017-04-03 | 2021-02-12 | Basf Beauty Care Solutions France Sas | Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale |
KR101953375B1 (ko) * | 2017-11-20 | 2019-02-28 | 고려대학교 산학협력단 | 다양하고 신규한 퓨코실 올리고당의 제조법 및 이의 용도 |
-
2021
- 2021-06-11 WO PCT/EP2021/065735 patent/WO2022008163A1/en active Search and Examination
- 2021-06-11 EP EP21730629.9A patent/EP4178528A1/en active Pending
- 2021-06-11 MX MX2023000423A patent/MX2023000423A/es unknown
- 2021-06-11 US US18/014,382 patent/US20230270653A1/en active Pending
- 2021-06-11 CN CN202180048959.0A patent/CN115867347A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4178528A1 (en) | 2023-05-17 |
WO2022008163A1 (en) | 2022-01-13 |
US20230270653A1 (en) | 2023-08-31 |
CN115867347A (zh) | 2023-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502793A1 (en) | Aadc polynucleotides for the treatment of parkinson`s disease | |
TWD192896S (zh) | 按摩器 | |
PH12015502788A1 (en) | Antibody formulations and methods | |
EA201891224A1 (ru) | Способы и системы для предоставления стимулов для головного мозга | |
MX2017013562A (es) | Reguladores de microbioma y usos relacionados de los mismos. | |
MX2018012655A (es) | Compuestos y metodos para tratamiento de afecciones neurologicas y cardiovasculares. | |
MX2009013353A (es) | Compuestos activadores de telomerasa y metodos para su uso. | |
MX2020006237A (es) | Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
MX2010001449A (es) | Bromhidrato de bupropion y aplicaciones terapeuticas. | |
PH12018500315A1 (en) | Fumagillol heterocyclic compounds and methods of making and using same | |
MX2017014245A (es) | Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas. | |
MY161197A (en) | Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions | |
PH12019500643A1 (en) | Antibodies that bind interleukin-2 and uses thereof | |
UA107204C2 (uk) | Протигрибкова композиція, що містить грибковий організм pythium oligandrum | |
WO2018178243A3 (en) | Dihydrotetrabenazine for use in the treatment a movement disorder | |
MX2021003515A (es) | Compuestos polimorficos y usos de los mismos. | |
PH12018501665A1 (en) | Process for preparing a silicone elastomer with hydrophilic actives and a personal care composition containing the elastomer | |
MX366927B (es) | Composición para cuidado de la piel que comprende nitruro de boro turboestrático. | |
NZ745185A (en) | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
JOP20210008A1 (ar) | أنواع أبيراز مذابة، وطرق لاستخدامها | |
MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2022005084A (es) | Formas sólidas de un modulador del receptor s1p a. | |
MX2023000423A (es) | Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades. | |
WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
EP4017880A4 (en) | USE OF BRAZIKUMAB TO TREAT CROHN'S DISEASE |